Biotek-snakken — Januar 2022
-
This Biotech Stock Just Collapsed; Why One Analyst Still Has Hope
Sutro stock collapsed Thursday — and was among the biggest biotech stock dives — after its ovarian cancer study disappointed investors.
Investor's Business Daily (www.investors.com)
-
Har du prøvet hjemmesiden?
-
Sukkeralf tænker du, at Ali måske ligefrem har dækket over problemer med ZW49? CFO har præsentation på J.P. Morgan Healthcare Conference på tirsdag (forventer at deltage...hvis det da kan give lidt info/vibes) - https://ir.zymeworks.com/events/event-details/40th-annual-jp-morgan-healthcare-conference
-
STENOCARE - Godkendelse fra Lægemiddelstyrelsen på medicinsk cannabis produkt https://www.proinvestor.com/boards/99952
-
Hvis man ser på Ali´s mål for Zymeworks, så har jeg svært ved at tro, at han selv vælger at træde tilbage - men da han omvendt heller ikke er røget ud med det samme, så må det jo være et kompromis. Hvad det så skyldes må vi se om kommer frem, men jeg tænker du kunne have lidt at gøre med at Ali store armbevægelser ikke helt holder vand - og investorerne ikke vil spytte flere penge i med ham i front
-
Servicemeddelelse:
Vi har fået en ny chat for banker og finans. -
My 3 Top Biopharma Stock Picks for 2022 https://www.proinvestor.com/investornyt/761717/my-3-top-biopharma-stock-picks-for-2022
-
Orphazyme A/S - ADR Shares Approach 52-Week Low - Market Mover https://www.proinvestor.com/investornyt/761705/orphazyme-a-s-adr-shares-approach-52-week-low-market-mover
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind